Skip to main content
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mSphere
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Editor's Pick Commentary | Host-Microbe Biology

mSphere of Influence: Frameshift—a Vision for Human Microbiome Research

Ariangela J. Kozik
Ariangela J. Kozik
aDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mSphere.00944-20
  • Article
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Ariangela J. Kozik studies the respiratory microbiome as it relates to asthma. In this mSphere of Influence article, she reflects on how two papers, “Time’s up to adopt a biopsychosocial model to address racial and ethnic disparities in asthma outcomes” (E. C. Matsui, A. S. Adamson, and R. D. Peng, Allergy Clin Immunol 143:2024–2025, 2019, https://doi.org/10.1016/j.jaci.2019.03.015) and “Health disparities and the microbiome” (K. Findley, D. R. Williams, E. A. Grice, and V. L. Bonham, Trends Microbiol 24:847–850, 2016, https://doi.org/10.1016/j.tim.2016.08.001), shape her approach to human microbiome research.

The views expressed in this article do not necessarily reflect the views of the journal or of ASM.

COMMENTARY

I have few vivid memories of my elementary school days. One is the smell. Some of the nation’s largest integrated steel mills, an oil refinery, several coal-fired power plants, lead smelters, toxics recyclers, chemical plants, and railyards stand within a 10-mile radius of the school. Every morning, even on sunny days, there was a thick blanket of haze that reeked of smoke, gasoline, and melting plastic. My other memory is how many of my northwestern Indiana school classmates went to the nurse’s office for their asthma medications each day.

Asthma is a chronic inflammatory disease of the respiratory system that affects adults and children. Minoritized populations, specifically Black and Hispanic persons, disproportionately experience adverse asthma outcomes. This increased burden is especially acute in pediatric asthma, with Black children two and four times as likely to be hospitalized or die from asthma than white children, respectively (1). Despite decades of asthma research, substantial progress toward understanding and mitigating these stark differences in outcomes has not been made. While the definitive cause of asthma is unknown, knowledge that the human microbiome is highly individualized, responsive to environmental exposures, and intricately connected to the immune system makes it a subject of research in this (2) and other chronic diseases (3, 4).

Studies have traditionally indicted the Black body for biological explanations of their disproportionate disease burden in the United States. Unsurprisingly, this framework has failed to meaningfully improve the lives and health of Black communities. This is the context within which two recent articles have influenced me in their call for a new approach to research. In their article “Time’s up to adopt a biopsychosocial model to address racial and ethnic disparities in asthma outcomes” (5), Matsui et al. discuss a study that matched Black and white subjects with asthma based on their community/family socioeconomic variables and environmental exposure variables, eliminating the racial disparity in asthma-related emergency department visits (6). In their discussion, they assert the need to develop research frameworks (especially research aimed at reducing racial disparities) that center the social determinants of health and biology. Without these considerations, the conventional biological models of racial disparities conflate race with biology, which fails to produce meaningful mechanistic insights or reduce disparities (7, 8). The authors affirm two important principles. (i) Race is a social construct, and it functions (in the United States) as a “conveniently measurable proxy” for other factors that influence health. It is critical to understand that the connections between race and these factors (health literacy, environment, social vulnerability, stress, etc.) did not occur by accident. They are the direct consequence of racism. The exploitative systems of racial classification were constructed to politically serve white supremacy. (ii) Conventional framing of biomedical studies that employ “race” as a potential causal factor actively ignores other factors that can shape the biology in a person or given population.

“Health disparities and the microbiome” by Findley et al. (9) discusses how the human microbiome is influenced by social and physical environments in addition to biological systems, which likely act collectively to inform disease progression. The authors discuss several studies that have examined differences in the microbiomes of “ethnically diverse” cohorts but are critically limited due to the lack of social, behavioral, and environmental data on study participants. It then describes a conceptual framework for human health and disease that “acknowledges three overlapping but distinct and complex areas of health research – the microbiome, biological processes, and the social/physical environment.” A critical tenet of both papers is that social/environmental factors must be considered potential mediators with measurable impacts on disease processes instead of confounders.

As a Black early-career scientist studying the link between asthma and the respiratory microbiome, these frameworks have laid the foundation for my approach to research. Boyd and colleagues describe racism as the mechanism by which racial categorizations have biological consequences (10). Reflecting on my childhood, the link between structural racism and my elementary school district comes into glaring focus. In the late 90s (and today), my school and the surrounding district were approximately 95% nonwhite. My school was also in a county with the highest rate of asthma hospitalizations compared to surrounding counties, and recent evidence has finally uncovered the severe environmental harms caused to the community, particularly, extremely high levels of airborne toxins and pollutants and an increased cancer risk far above the national average (11).

Human microbial diversity (much like genetic diversity) is expansive and irreverent to our constructed social categories. Therefore, as microbiologists, we must be conscious of how microbiome studies that focus on minoritized populations and/or health disparities are framed. Currently, an unspoken single group (cis, hetero, white, healthy, with access to health care) is considered the standard, while the clinical or microbial features and outcomes of others are considered aberrations or even diseased. This approach furthers the notions of biological superiority/inferiority that have historically driven the scientific and medical discourse. As a scientific community, we must reconstruct our methodologies to uproot these racist practices. As an asthma researcher, this means interrogating the host, environmental, and lifestyle data we collect. A larger or more diverse study cohort is not sufficient. We must also collect data to further understand our study participants and their environmental context: physical environment, stress (economic and psychological), social factors (poverty, segregation, exposure to violence), quality health care access, and other variables to interrogate their impacts on the microbiome.

Undergoing this conceptual shift and implementing these models will be challenging. It will likely require the development of innovative statistical approaches and methods by cross-disciplinary research collaborations and community partnerships to integrate these complex, multifaceted data. It also requires a commitment by funding agencies to facilitate these studies and validate this work as crucial to our progress in science, medicine, and public health. Finally, scientific publishers must hold microbiome studies accountable in integrating the biopsychosocial model, thus affirming the broad relevance of these scholarly discussions and pushing the scientific enterprise toward equity.

  • Copyright © 2020 Kozik.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

REFERENCES

  1. 1.↵
    Asthma Disparities Working Group. 2012. President’s task force on environmental health risks and safety risks to children. Coordinated federal action plan to reduce racial and ethnic asthma disparities. Asthma Disparities Working Group, Environmental Protection Agency, Washington, DC.
  2. 2.↵
    1. Kozik AJ,
    2. Huang YJ
    . 2019. The microbiome in asthma: role in pathogenesis, phenotype, and response to treatment. Ann Allergy Asthma Immunol 122:270–275. doi:10.1016/j.anai.2018.12.005.
    OpenUrlCrossRef
  3. 3.↵
    1. Durack J,
    2. Lynch SV
    . 2019. The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med 216:20–40. doi:10.1084/jem.20180448.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    NIH Human Microbiome Portfolio Analysis Team. 2019. A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007–2016. Microbiome 7:31. doi:10.1186/s40168-019-0620-y.
    OpenUrlCrossRef
  5. 5.↵
    1. Matsui EC,
    2. Adamson AS,
    3. Peng RD
    . 2019. Time’s up to adopt a biopsychosocial model to address racial and ethnic disparities in asthma outcomes. J Allergy Clin Immunol 143:2024–2025. doi:10.1016/j.jaci.2019.03.015.
    OpenUrlCrossRef
  6. 6.↵
    1. Fitzpatrick AM,
    2. Gillespie SE,
    3. Mauger DT,
    4. Phillips BR,
    5. Bleecker ER,
    6. Israel E,
    7. Meyers DA,
    8. Moore WC,
    9. Sorkness RL,
    10. Wenzel SE,
    11. Bacharier LB,
    12. Castro M,
    13. Denlinger LC,
    14. Erzurum SC,
    15. Fahy JV,
    16. Gaston BM,
    17. Jarjour NN,
    18. Larkin A,
    19. Levy BD,
    20. Ly NP,
    21. Ortega VE,
    22. Peters SP,
    23. Phipatanakul W,
    24. Ramratnam S,
    25. Teague WG
    . 2019. Racial disparities in asthma-related health care use in the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol 143:2052–2061. doi:10.1016/j.jaci.2018.11.022.
    OpenUrlCrossRef
  7. 7.↵
    1. Cooper RS
    . 2013. Race in biological and biomedical research. Cold Spring Harb Perspect Med 3:a008573. doi:10.1101/cshperspect.a008573.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Hardeman RR,
    2. Medina EM,
    3. Kozhimannil KB
    . 2016. Structural racism and supporting black lives — the role of health professionals. N Engl J Med 375:2113–2115. doi:10.1056/NEJMp1609535.
    OpenUrlCrossRef
  9. 9.↵
    1. Findley K,
    2. Williams DR,
    3. Grice EA,
    4. Bonham VL
    . 2016. Health disparities and the microbiome. Trends Microbiol 24:847–850. doi:10.1016/j.tim.2016.08.001.
    OpenUrlCrossRef
  10. 10.↵
    1. Boyd RW,
    2. Lindo EG,
    3. Weeks LD,
    4. McLemore MR
    . 2 July 2020. On racism: a new standard for publishing on racial health inequities. Health Affairs Blog 10.1377/hblog20200630.939347.
  11. 11.↵
    Hoosier Environmental Council. 2019. Assessment of environmental justice needs in Northern Lake County communities. Hoosier Environmental Council, Indianapolis, IN.
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
mSphere of Influence: Frameshift—a Vision for Human Microbiome Research
Ariangela J. Kozik
mSphere Sep 2020, 5 (5) e00944-20; DOI: 10.1128/mSphere.00944-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mSphere article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
mSphere of Influence: Frameshift—a Vision for Human Microbiome Research
(Your Name) has forwarded a page to you from mSphere
(Your Name) thought you would be interested in this article in mSphere.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
mSphere of Influence: Frameshift—a Vision for Human Microbiome Research
Ariangela J. Kozik
mSphere Sep 2020, 5 (5) e00944-20; DOI: 10.1128/mSphere.00944-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • COMMENTARY
    • REFERENCES
  • Info & Metrics
  • PDF

KEYWORDS

asthma
disparities
microbiome

Related Articles

Cited By...

About

  • About mSphere
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • Embargo Policy
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Types of Articles
  • Getting Started
  • Ethics
  • Contact Us

Follow #mSphereJ

@ASMicrobiology

       

 

Website feedback

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2379-5042